Human A1 expression in acute myeloid leukemia (AML)
While both peptides aim to increase growth hormone levels, they work differently and may suit different health and performance goals
Less commonly recognized but still valid qualifying conditions include prediabetes (elevated fasting glucose or A1C between 5.7-6.4%), polycystic ovary syndrome, non-alcoholic fatty liver disease, osteoarthritis of weight-bearing joints, and chronic kidney disease
Acetyl Hexapeptide-8 (Argireline) and niacinamide round out a well-formulated serum, and Centella asiatica supports post-procedure barrier recovery
Birkenfeld reports that his department at University Hospital Tbingen has received research support from AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Novo Nordisk
The organization has impacted over 2.9 million lives over the last decade through its CSR interventions